Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01745055 · ClinicalTrials.gov registry record · Phase 1
Co-Administration Of Methotrexate And CP-690,550
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01745055 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 12 participants.
The verdict
NCT01745055, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study was designed to estimate the effects of methotrexate (MTX) on the pharmacokinetics (PK) of CP-690,550 when administered to subjects with rheumatoid arthritis (RA), to estimate the effects of CP-690,550 on the PK of MTX and to evaluate the short-term safety and tolerability of co-administration of CP-690,550 and MTX.
Interventions
- DRUG Methotrexate (MTX)
- DRUG CP-690,550 (tofacitinib)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-04 |
| Est. Completion | 2006-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01745055
The ClinicalTrials.gov registry entry for NCT01745055 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methotrexate (MTX) is the first listed.
NCT01745055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01745055 about?
NCT01745055 is a clinical study titled "Co-Administration Of Methotrexate And CP-690,550". This study was designed to estimate the effects of methotrexate (MTX) on the pharmacokinetics (PK) of CP-690,550 when administered to subjects with rheumatoid arthritis (RA), to estimate the effects of CP-690,550 on the PK of MTX and to evaluate the short-term safety and tolerability of co-administr...
What is the current status of trial NCT01745055?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2005-04. Estimated completion is 2006-06.
What interventions are being tested in trial NCT01745055?
The interventions under investigation include: Methotrexate (MTX) (DRUG), CP-690,550 (tofacitinib) (DRUG).
Who is sponsoring clinical trial NCT01745055?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.